查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1844102

血栓移除器械市場（按器械類型、最終用戶和應用分類）—2025-2032年全球預測

Blood Clot Retrieval Devices Market by Device Type, End User, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，血栓移除裝置市場規模將達到 60.6 億美元，複合年成長率為 14.78%。

主要市場統計數據
基準年 2024 20.1億美元
預計年份：2025年 23億美元
預測年份：2032年 60.6億美元
複合年成長率 (%) 14.78%

簡要介紹影響血栓移除裝置和手術流程的技術、臨床和監管因素

血栓移除裝置已從最初的簡易機械器械發展成為高度工程化的血管內系統，能夠在危及生命的血栓事件中快速恢復灌注。過去十年，裝置創新主要集中在提高其在迂曲血管內的操控性、提升血栓捕獲和取出效率以及最大限度減少血栓移除中的遠端栓塞。影像導引和導管技術的同步進步，共同創造了一個協同發展的環境，使得裝置設計、手術技術和臨床方案得以同步演進。

臨床實務越來越注重時間敏感型介入治療，因為器械性能直接影響神經系統和心肺功能的預後。因此，由介入神經科、血管外科醫生和介入放射科醫生組成的多學科團隊正日益規範手術流程，以最佳化從入院到再灌注的時間。同時，製造商也不斷改進產品，研發新的架構，優先考慮可追蹤性、徑向力控制和吸力相容性，以適應更廣泛的血栓成分和解剖結構變異。

監管互動和證據蒐集也日趨成熟。如今，器械核准通常需要可靠的手術數據、已建立的手術比較以及上市後監測。因此，器械研發的策略規劃必須包含臨床試驗設計、衛生經濟學模型以及早期相關人員參與，以支持醫院採納和與支付方的互動。總而言之，臨床療效、手術效率和供應鏈韌性這三者將共同塑造該領域的競爭格局。

技術進步、臨床路徑改革和商業模式的演變，正從根本上改變血栓移除器材的格局。

血栓移除器械領域正經歷顯著的變革，這主要受技術進步、臨床通訊協定的演變以及人們對治療效果和成本預期轉變的推動。在器械層面，製造商正在推出混合結構，將機械支架樣元件與吸力相容的管腔結合。這些混合設計旨在提高首次通過率，同時降低手術複雜性。同時，影像和導航平台使得器械能夠在遠端和迂曲的解剖結構中實現更精準的部署，從而擴大了可治療病變的範圍，並促使人們重新評估介入治療的適應症。

在臨床上，隨著中風診療體系和血管疾病診療計畫優先考慮快速分診、院前通知和簡化院內工作流程，診療路徑正變得日益整合。這種運作重點促使人們採用能夠縮短手術時間和減少手術變異性的器械，從而提高首次手術成功率等指標並最大限度地減少器械更換。同時，跨領域培訓和基於模擬的資格認證正在減少操作者差異，這反過來又影響採購決策和供應商支援模式。

從策略角度來看，這些轉變正迫使供應商重新思考其商業模式。醫療服務提供者越來越重視包含培訓、即時流程支援和數據分析（用於監測治療效果）在內的捆綁式服務。同時，對全球供應鏈的考慮以及製造地多元化的需求，正在推動夥伴關係和本地化生產策略的建立。這些變化並非漸進式的，而是重新定義了臨床表現、服務模式和競爭差異化的預期。

分析2025年美國關稅對醫療設備採購、定價策略和供應鏈韌性的多面向營運和商業影響

2025年關稅和貿易措施的實施，為依賴全球採購零件和成品設備的製造商、經銷商和醫療保健系統帶來了新的挑戰。關稅帶來的成本壓力將波及價值鏈的多個環節，包括原料採購、契約製造和跨境分銷。不斷上漲的成本迫使製造商重新審視供應商選擇標準，考慮替代材料和零件，並盡可能加快關鍵製造流程的本地化進程。因此，近岸外包和產能多元化策略正從緊急計畫轉向主動的供應鏈重組。

除了直接的成本影響外，關稅還會影響與醫療服務提供者和支付方的價格談判，尤其是在報銷率受限的地區。醫院和門診手術中心可能面臨採購預算緊張的問題，因此他們優先選擇手術效率高、輔助服務需求低的設備。為了緩解利潤壓縮，供應商正在尋求附加價值服務、延長保固期和基本契約，以維持商業性生存能力。

監管和海關合規負擔也隨之加重，需要更完善的文件、更長的前置作業時間和更大的庫存緩衝，以避免流程中斷。這些營運調整也會影響臨床安排和融資時間表。因此，具有前瞻性的公司正在將情境規劃與對供應商環節的深入了解相結合，以在持續的貿易摩擦面前，維持醫療保健的連續性、控制成本波動並保證產品供應。

利用與設備架構、臨床環境和特定適應症的手術需求相關的可操作細分訊息，為開發和採購提供資訊。

細分市場分析揭示了產品開發、臨床應用和籌資策略如何因器材類型、醫療環境和臨床適應症而異。就器械類型而言，抽吸導管的操作特點在於直接抽吸，通常用於預期會形成柔軟易碎血栓的病例。血栓摘取支架則提供機械嚙合和徑向支撐，適用於組織型血栓。整合了抽吸和取栓機制的組合系統旨在捕捉更廣泛的血栓形態，同時最佳化首次通過率，無論採用順序部署還是同時部署。這種差異化影響研發優先順序、臨床訓練需求以及手術中心的庫存策略。

就最終用戶而言，門診手術中心、綜合醫院和血管專科診所的採購理由和營運限制各不相同。門診中心優先考慮的是吞吐量和單次就診成本，而醫院則通常需要在心臟和神經血管計畫的急診準備和資本規劃之間取得平衡。在醫院內部，心臟專科醫院和神經血管專科中心各自製定能力矩陣，使設備組合與關鍵手術量和醫生專業水平相匹配。這些機構差異會影響供應商的合作方式，包括支援方案、培訓方法和首選合約結構。

臨床應用進一步細化了器械選擇和手術方案製定。深層靜脈栓塞症形成，無論遠端或近端，都需要能夠維護靜脈完整性並最大限度減少血栓後遺症的器械和手術方案。缺血性中風的治療需要針對腦血管脆弱性和快速再灌注進行最佳化的器械，適用於急性缺血到亞急性及慢性阻塞的情況。肺動脈栓塞的治療需要能夠在維持血流動力學穩定的同時清除大量血栓的系統。由於每種適應症都需要獨特的臨床表現，因此，分段式的開發和商業化策略對於使產品系列與實際手術情況相符至關重要。

區域醫療基礎設施、監管多樣性和能力建設優先事項如何驅動差異化的招聘模式和打入市場策略

區域動態以多種方式塑造臨床實踐模式、監管管道和供應鏈設計，對醫療設備的採用和供應商策略產生重大影響。在美洲，密集的專科醫療中心和綜合中風系統網路正在加速流程標準化，許多醫療機構都在投資建設中風基礎設施和多學科中風團隊。這種環境有利於那些展現出明顯流程優勢和可衡量的工作流程效率提升的醫療器材的快速普及，同時也有利於那些提供全面培訓和上市後結果分析的供應商。

歐洲、中東和非洲的監管環境和醫院能力各不相同，因此量身定做的市場准入參與策略和臨床證據至關重要。歐洲核心市場的醫療服務提供者通常重視臨床數據對比和衛生技術評估，而新興市場的醫療服務提供者則可能更注重成本效益和供應可靠性。因此，製造商通常會採取差異化的市場准入策略，將監管市場中強力的臨床文件與針對不同醫療環境的有針對性的能力建設舉措和靈活的商業模式相結合。

快速的都市化、不斷擴展的三級醫療網路以及對介入培訓的投入，正推動亞太地區手術量的成長。這種成長使得可擴展的解決方案變得特別重要，這些解決方案既能滿足大型醫療機構的需求，又能兼顧當地醫院的便利性。監管協調的推進以及對本地製造業投資的增加，也在重塑競爭格局，促使跨國供應商考慮建立區域夥伴關係和生產基地，以加快市場准入並實現永續的業務營運。

競爭與合作策略著重於臨床差異化、服務整合與生命週期組合管理，以確保長期應用。

血栓移除器械領域的競爭格局呈現出多元化的態勢，既有成熟的平台型參與企業，也有創新型挑戰者，還有利用自身手術資源和服務生態系統來提升產品普及率的垂直整合型醫療設備公司。大型製造商和新興參與企業都致力於透過展示手術優勢來實現臨床差異化，例如提高首次手術成功率、減少器械更換次數以及簡化操作流程。為了實現這些目標，各公司都在投資於器械的迭代最佳化、支持輔助手術的模組化系統以及旨在縮短學習曲線並強化最佳實踐的綜合性臨床醫生教育計畫。

此外，對於那些希望加快產品上市速度、拓展產品系列，同時又不想承擔全部內部研發成本的公司而言，策略夥伴關係和授權協議正變得越來越普遍。此類合作模式涵蓋分銷協議、臨床研究聯盟以及共用生產能力等。那些將設備創新與強大的服務產品（例如術中支援、模擬培訓和數據分析）相結合的供應商，往往能夠與大批量生產中心和專業專案建立更緊密的合作關係。

最後，公司的策略整合了生命週期管理計劃，該計劃涵蓋了設備的逐步改進、跨產品相容性以及對上市後監測的承諾。這種長期的產品組合管理方法有助於公司滿足監管要求，同時保持臨床相關性，並協助醫院採購委員會優先考慮具有顯著長期價值的產品。

為製造商和醫療保健系統提供具體可行的建議，以協調臨床證據、培訓、供應鏈彈性以及以金額為準的商業模式。

在流程規範日益嚴格、供應鏈日益複雜的環境下，產業領導者可以採取實際措施，協調商業性、臨床和營運目標。首先，在產品開發早期階段就整合臨床證據生成，可確保醫療設備符合實際操作需求和監管要求，同時提供採購委員會所需的比較結果。透過讓臨床試驗設計與目標最終用戶相匹配，企業可以產生與心臟病醫院、神經血管中心和高流量門診機構等直接相關的證據。

其次，投資全面的培訓和流程支援計畫可以減少操作人員的差異，並加強供應商與醫療機構之間的聯繫。基於模擬的資格認證、按需流程指導和結構化的術後總結匯報有助於將新設備整合到臨床工作流程中，並提高首次通過率。第三，為了緩解關稅相關的成本壓力和物流中斷，應優先考慮供應鏈的韌性，具體措施包括多元化採購、策略性庫存佈局以及潛在的區域製造夥伴關係關係。使採購計畫與醫院的資本週期保持一致，並提高供應商節點的透明度，可以進一步減少營運摩擦。

最後，商業模式應不斷發展，納入以結果為導向的合約、配套服務以及靈活的定價結構，從而體現流程效率和降低併發症發生率的價值。這種方法有助於醫院在價格敏感的環境下證明採用這些服務的合理性，同時保障供應商的利潤。透過結合實證實踐、培訓、穩健的供應鏈和適應性強的商業策略，企業領導者可以最佳化其產品組合，以實現永續應用並獲得競爭優勢。

透明的、三角驗證的調查方法，結合了臨床醫生的第一手見解、程序資料檢驗和監管管道分析，確保得出可操作的結論。

本報告的調查方法採用了一種三角測量法，整合了主要相關人員訪談、流程資料分析以及監管和臨床文獻綜述。主要資料來源包括對介入臨床醫生、醫院採購負責人和器械工程師的結構化訪談，旨在了解他們對器械性能、工作流程影響和採購決策因素的本地化觀點。這些定性見解與手術結果資料集和同行評審的臨床研究進行了交叉比對，以檢驗性能聲明並識別器械選擇和臨床決策中的模式。

同時，我們分析了監管申報文件和指導文件，以梳理主要司法管轄區的核准管道、上市後監管預期和標籤限制。供應鏈評估包括供應商網路分析、組件採購分析以及與製造外包製造商的溝通，以識別生產瓶頸和供應多元化的機會。整合這些訊息，我們得以全面了解醫療器材的生命週期考量，涵蓋從設計到臨床應用、商業化和上市後支援的各個階段。

在整個過程中，我們始終專注於確保所有解讀均基於當前的臨床實踐和監管實際情況。我們採用了過渡性檢查和反覆的專家同行評審，以保持對不斷發展的程序標準的遵循，並確保研究結果對生產、臨床營運和採購決策者俱有實際指導意義。

策略性結論重點闡述了臨床表現、證據產生和供應韌性如何共同決定血栓移除技術的長期應用。

總之，血栓移除領域融合了精密的器材工程、高風險的臨床決策和複雜的商業性動態。器械架構和影像引導技術的創新不斷拓展手術的可能性，而臨床工作流程和資格認證的變革則提高了器械性能和手術效率的標準。關稅帶來的供應鏈壓力和區域監管差異進一步凸顯了建立具有韌性的製造地和差異化打入市場策略的必要性。

為了因應這種環境，相關人員必須使產品開發與不同終端使用者的實際需求保持一致，產生可靠的臨床證據以證明手術效果，並實施靈活的商業模式，充分考慮醫院和專科診所的運作實際情況。這樣做不僅能幫助製造商和醫療系統應對短期挑戰，還能讓他們從長期轉向更整合、以結果為導向的醫療模式轉變中獲益。最終，能否提供具有臨床意義的益處，並輔以可重複的證據和可靠的供應，將決定哪些解決方案能夠獲得廣泛且持續的應用。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 抽吸血栓切除術合併支架取栓裝置的應用日益增多，以提高血管再通率
  • 開發具有更高柔韌性和在迂曲血管中導航能力的新一代導管設計
  • 機械取栓術與動脈內溶栓術結合在急性中風通訊協定中變得越來越重要。
  • 將血栓切除裝置與即時影像支援相結合，以最佳化血栓切除術的準確性
  • 缺血性中風發病率的上升推動了對快速血栓清除解決方案的需求。
  • 生物相容性塗層技術的進步可減少取栓裝置的血栓形成
  • 人工智慧導引裝置定位系統的出現，提高了血栓切除手術的手術效率
  • 將血栓切除裝置的適應症從神經血管應用擴展到周邊動脈和靜脈應用

第6章美國關稅的累積影響，2025年

第7章 人工智慧的累積影響，2025年

第8章 按器械類型血栓移除器械市場

  • 吸管
  • 複雜系統
    • 連續收集機
    • 同時收集機
  • 支架取出機

第9章 依最終用戶血栓移除器械市場

  • 門診手術中心
  • 醫院
    • 心臟醫院
    • 神經血管中心
  • 血管專科診所

第10章 按應用分類的血栓移除器械市場

  • 深層靜脈栓塞症
    • 遠端深層靜脈栓塞症
    • 近端深層靜脈栓塞症
  • 缺血性中風
    • 急性缺血性腦中風
    • 亞急性及慢性阻塞
  • 肺動脈栓塞
    • 嚴重肺動脈栓塞
    • 亞大塊肺動脈栓塞

第11章血栓移除器械市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章血栓移除器械市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 各國血栓移除器材市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Medtronic plc
    • Stryker Corporation
    • Penumbra, Inc.
    • Boston Scientific Corporation
    • MicroPort Scientific Corporation
    • Terumo Corporation
    • Johnson & Johnson
    • Integra LifeSciences Holdings Corporation
    • Cardinal Health, Inc.
    • AngioDynamics, Inc.
Product Code: MRR-A26E0E574192

The Blood Clot Retrieval Devices Market is projected to grow by USD 6.06 billion at a CAGR of 14.78% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.01 billion
Estimated Year [2025] USD 2.30 billion
Forecast Year [2032] USD 6.06 billion
CAGR (%) 14.78%

A concise introduction to the technological, clinical, and regulatory forces reshaping blood clot retrieval devices and procedural pathways

Blood clot retrieval devices have advanced from rudimentary mechanical implements to highly engineered endovascular systems capable of rapidly restoring perfusion in life-threatening thrombotic events. Over the past decade, device innovation has concentrated on improving navigability within tortuous vasculature, enhancing clot engagement and extraction efficiency, and minimizing distal embolization during retrieval. Concurrent advancements in imaging guidance and catheter technology have created a synergistic environment in which device design, procedural techniques, and clinical protocols evolve in concert.

In clinical settings, the emphasis has shifted toward time-sensitive interventions where device performance directly affects neurological and cardiopulmonary outcomes. As a result, multidisciplinary teams that integrate interventional neurologists, vascular surgeons, and interventional radiologists are increasingly standardizing procedural pathways to optimize door-to-reperfusion times. Meanwhile, manufacturers are pursuing iterative improvements and novel architectures that prioritize trackability, radial force control, and aspiration compatibility to accommodate a wider range of clot compositions and anatomical variations.

Regulatory engagement and evidence generation have also matured. Device approvals now commonly require robust procedural data, comparative metrics against established techniques, and post-market surveillance commitments. Consequently, strategic planning for device development must encompass clinical trial design, health economic modeling, and early stakeholder engagement to support hospital adoption and payer dialogue. Taken together, these forces frame an environment where clinical efficacy, procedural efficiency, and supply chain resilience all shape the competitive contours of the sector.

How convergent technological advances, clinical pathway reforms, and evolving commercial models are fundamentally transforming the blood clot retrieval device landscape

The landscape for clot retrieval devices is undergoing transformative shifts driven by converging technological advances, evolving clinical protocols, and changing ecosystem expectations around outcomes and cost. At the device level, manufacturers are introducing hybrid architectures that combine mechanical stent-like elements with aspiration-compatible lumens, and those hybrid designs aim to improve first-pass efficacy while reducing procedural complexity. Simultaneously, imaging and navigation platforms have enabled more precise device deployment in distal and tortuous anatomy, expanding the range of treatable lesions and prompting re-evaluation of inclusion criteria for intervention.

Clinically, care pathways are becoming more integrated as stroke systems of care and vascular programs prioritize rapid triage, pre-hospital notification, and streamlined in-hospital workflows. This operational emphasis has incentivized devices that reduce procedure time and variability, and it has elevated metrics such as first-pass success and minimized device exchanges. In parallel, cross-disciplinary training and simulation-based credentialing are reducing operator-dependent variability, which in turn influences purchasing decisions and vendor support models.

From a strategic standpoint, these shifts are prompting suppliers to rethink commercial models. Providers increasingly value bundled offerings that include training, real-time procedural support, and data analytics to monitor outcomes. At the same time, global supply chain considerations and the desire for diversified manufacturing footprints are encouraging partnerships and regionalized production strategies. Together, these changes are not incremental; they are redefining expectations across clinical performance, service models, and competitive differentiation.

Analyzing the multifaceted operational and commercial repercussions of United States tariffs in 2025 on device sourcing, pricing strategies, and supply chain resilience

The imposition of tariffs and trade measures in 2025 has introduced new layers of complexity for manufacturers, distributors, and health systems that rely on globally sourced components and finished devices. Tariff-induced cost pressures manifest across multiple nodes of the value chain, including raw-material procurement, contract manufacturing, and cross-border distribution. These increased costs compel manufacturers to re-evaluate supplier selection criteria, explore alternative materials or components, and accelerate initiatives to localize critical manufacturing steps where feasible. As a consequence, nearshoring and capacity diversification strategies have moved from contingency planning to active supply chain redesign.

In addition to direct cost implications, tariffs influence pricing negotiations with healthcare providers and payers, particularly in regions where reimbursement rates are constrained. Hospitals and ambulatory surgical centers may face tighter procurement budgets and therefore prioritize devices that demonstrate robust procedural efficiency and lower ancillary service requirements. To mitigate margin compression, suppliers are pursuing value-added services, extended warranties, and outcome-based contracting to preserve commercial viability.

Regulatory and customs compliance burdens have also increased, requiring enhanced documentation, longer lead times, and greater inventory buffers to avoid procedural disruptions. These operational adaptations have ripple effects on clinical scheduling and capital procurement timelines. Therefore, forward-looking organizations are combining scenario planning with more granular visibility into supplier nodes to maintain continuity of care, manage cost volatility, and sustain product availability in the face of persistent trade friction.

Actionable segmentation intelligence linking device architectures, clinical settings, and indication-specific procedural demands to inform development and procurement

Insight into segmentation reveals how product development, clinical adoption, and procurement strategies diverge across device typologies, care settings, and clinical indications. When device type is considered, aspiration catheters offer a procedural profile centered on direct suction and are frequently selected for cases where soft, friable thrombus is anticipated; stent retrievers provide mechanical engagement and radial support suitable for organized clots; and combined systems that integrate aspiration with retriever mechanics-whether deployed sequentially or simultaneously-aim to capture a broader spectrum of thrombus morphologies while optimizing first-pass efficacy. This differentiation impacts R&D prioritization, clinical training requirements, and inventory strategies at procedural centers.

Regarding end users, ambulatory surgical centers, general hospitals, and specialized vascular clinics present distinct purchasing rationales and operational constraints. Ambulatory centers emphasize throughput and cost per episode, whereas hospitals often balance acute care readiness with capital planning across cardiac and neurovascular programs. Within hospitals, cardiac hospitals and dedicated neurovascular centers develop unique competency matrices and device formularies aligned with their dominant procedural volumes and specialist expertise. These institutional distinctions shape vendor engagement approaches, including support packages, training modalities, and preferred contract structures.

Clinical application further stratifies device selection and procedural planning. Deep vein thrombosis cases, whether distal or proximal, demand devices and techniques that preserve venous integrity and minimize post-thrombotic sequelae. Ischemic stroke interventions, spanning acute ischemic presentations and subacute or chronic occlusions, require devices optimized for cerebral vessel fragility and rapid reperfusion. Pulmonary embolism treatment, across massive and submassive presentations, necessitates systems capable of extracting large clot burdens while maintaining hemodynamic stability. Each indication imposes discrete clinical performance requirements, and therefore segmentation-aware development and commercialization strategies are essential for aligning product portfolios with procedural realities.

How regional healthcare infrastructure, regulatory diversity, and capacity-building priorities drive differentiated adoption patterns and market entry strategies

Regional dynamics shape clinical practice patterns, regulatory pathways, and supply chain design in ways that materially affect device adoption and vendor strategy. In the Americas, a dense network of tertiary centers and integrated stroke systems has accelerated procedural standardization, with many institutions investing in stroke-ready infrastructure and multidisciplinary stroke teams. This environment supports rapid adoption of devices that demonstrate clear procedural advantages and measurable improvements in workflow efficiency, and it also favors vendors that offer comprehensive training and post-market outcome analytics.

In Europe, the Middle East & Africa region, heterogeneous regulatory landscapes and variable hospital capabilities create a market where tailored entry strategies and localized clinical evidence are paramount. Providers in core European markets often emphasize comparative clinical data and health technology assessments, whereas centers in emerging markets may prioritize cost-effectiveness and supply reliability. Consequently, manufacturers often pursue differentiated market access approaches, combining robust clinical dossiers in regulated markets with targeted capacity-building initiatives and flexible commercial models in varied healthcare settings.

In the Asia-Pacific region, rapid urbanization, expanding tertiary care networks, and investments in interventional training are driving procedural volumes upward. This growth is accompanied by an emphasis on scalable solutions that cater to high-volume centers while remaining accessible to regional hospitals. Regulatory harmonization efforts and increasing local manufacturing investments are also shaping the competitive environment, prompting multinational suppliers to consider regional partnerships and production footprints to support faster market entry and sustainable operations.

Competitive and collaborative company strategies focused on clinical differentiation, service integration, and lifecycle portfolio management to secure durable adoption

Competitive dynamics in the clot retrieval device space reflect a blend of entrenched platform players, innovative challengers, and vertically integrated medical device companies that leverage surgical capital and service ecosystems to strengthen adoption. Leading manufacturers and emerging entrants alike focus on clinical differentiation through demonstrable procedural benefits such as increased first-pass success, reduced device exchanges, and simplified operator workflows. To achieve these outcomes, companies are investing in iterative device optimization, modular systems that support complementary procedural techniques, and comprehensive clinician education programs that shorten learning curves and reinforce best practices.

Moreover, strategic partnerships and licensing arrangements are increasingly prevalent as firms seek to accelerate time-to-market and broaden product portfolios without incurring the full cost of in-house development. These collaborative models extend to distribution agreements, clinical research consortia, and shared manufacturing capacity. Vendors that pair device innovation with strong service offerings-such as intra-procedural support, simulation training, and data analytics-tend to establish stickier relationships with high-volume centers and specialty programs.

Finally, corporate strategies are integrating lifecycle management plans that consider incremental device improvements, compatibility across product families, and post-market surveillance commitments. This long-view approach to portfolio management helps firms navigate regulatory expectations while maintaining clinical relevance and supporting hospital procurement committees that prioritize demonstrable long-term value.

Concrete, implementable recommendations for manufacturers and health systems to align clinical evidence, training, supply resilience, and value-based commercial models

Industry leaders can take concrete steps to align commercial, clinical, and operational objectives in an environment of accelerating procedural expectations and supply chain complexity. First, integrating clinical evidence generation into product development from early stages will ensure that devices meet practical procedural needs and regulatory requirements, while also producing the comparative outcomes required by procurement committees. By coordinating clinical trial design with target end users, companies can generate evidence that is directly relevant to cardiac hospitals, neurovascular centers, and high-volume ambulatory facilities alike.

Second, investing in comprehensive training and procedural support programs reduces operator variability and strengthens vendor ties with institutions. Simulation-based credentialing, on-demand procedural coaching, and structured post-procedure debriefs help embed new devices into clinical workflows and enhance first-pass performance metrics. Third, supply chain resilience must be prioritized through diversified sourcing, strategic inventory positioning, and potential regional manufacturing partnerships to mitigate tariff-related cost pressures and logistics disruptions. Aligning procurement timelines with hospital capital cycles and enhancing visibility across supplier nodes will further reduce operational friction.

Finally, commercial models should evolve to include outcome-oriented contracting, bundled services, and flexible pricing structures that reflect the value of procedural efficiency and reduced complication rates. These approaches make it easier for hospitals to justify adoption while preserving vendor margins in price-sensitive environments. By combining evidence generation, training, supply chain robustness, and adaptive commercial strategies, leaders can position their portfolios for sustainable adoption and competitive resilience.

A transparent, triangulated research methodology combining primary clinician insights, procedural data validation, and regulatory pathway analysis to ensure actionable conclusions

The research underpinning this report applied a triangulated methodology that integrates primary stakeholder interviews, procedural data analysis, and regulatory and clinical literature review. Primary inputs included structured interviews with interventional clinicians, hospital procurement leaders, and device engineers to capture frontline perspectives on device performance, workflow impacts, and purchasing determinants. These qualitative insights were cross-referenced with procedural outcome datasets and peer-reviewed clinical studies to validate performance claims and to identify patterns in device selection and clinical decision-making.

In parallel, regulatory filings and guidance documents were analyzed to map approval pathways, post-market surveillance expectations, and labeling constraints across major jurisdictions. Supply chain assessments incorporated supplier network mapping, component sourcing analysis, and conversations with contract manufacturers to understand production bottlenecks and opportunities for supply diversification. The synthesis of these streams facilitated a comprehensive view of device lifecycle considerations, from design and clinical adoption to commercialization and post-market support.

Throughout, care was taken to ensure that interpretations remain grounded in current clinical practice and regulatory realities. Transitional checks and iterative peer reviews with subject-matter experts were employed to maintain fidelity to evolving procedural standards and to ensure the research outputs remain actionable for decision-makers in manufacturing, clinical operations, and procurement.

A strategic conclusion highlighting how clinical performance, evidence generation, and supply resilience converge to determine durable adoption of clot retrieval technologies

In conclusion, the blood clot retrieval space sits at the intersection of sophisticated device engineering, high-stakes clinical decision-making, and complex commercial dynamics. Innovation in device architecture and imaging guidance is expanding the boundaries of what is treatable, while changes in clinical workflows and credentialing are raising the bar for device performance and procedural efficiency. Tariff-driven supply chain stresses and regional regulatory heterogeneity further underscore the necessity for resilient manufacturing footprints and differentiated market-access strategies.

To navigate this environment, stakeholders must align product development with the real-world needs of diverse end users, generate robust clinical evidence that speaks to procedural outcomes, and implement flexible commercial models that recognize the operational realities of hospitals and specialty clinics. By doing so, manufacturers and health systems can not only manage near-term disruptions but also capitalize on longer-term shifts toward more integrated, outcome-focused care models. Ultimately, the ability to deliver clinically meaningful benefits, supported by reproducible evidence and reliable supply, will determine which solutions achieve broad and sustained adoption.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of aspiration thrombectomy combined with stent retrievers for improved recanalization rates
  • 5.2. Development of next generation catheter designs with enhanced flexibility and navigation in tortuous vessels
  • 5.3. Growing emphasis on combining mechanical thrombectomy with intra-arterial thrombolytic therapy in acute stroke protocols
  • 5.4. Integration of real-time imaging support with thrombectomy devices for optimized clot retrieval accuracy
  • 5.5. Increasing prevalence of ischemic stroke driving demand for rapid blood clot retrieval solutions
  • 5.6. Advancements in biocompatible coating technologies to reduce thrombogenicity of retrieval devices
  • 5.7. Emergence of AI-guided device positioning systems to augment procedural efficiency in thrombectomy procedures
  • 5.8. Expanding indications for thrombectomy devices in peripheral arterial and venous applications beyond neurovascular use

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Clot Retrieval Devices Market, by Device Type

  • 8.1. Aspiration Catheter
  • 8.2. Combined System
    • 8.2.1. Sequential Retrievers
    • 8.2.2. Simultaneous Retrievers
  • 8.3. Stent Retriever

9. Blood Clot Retrieval Devices Market, by End User

  • 9.1. Ambulatory Surgical Center
  • 9.2. Hospital
    • 9.2.1. Cardiac Hospital
    • 9.2.2. Neurovascular Center
  • 9.3. Specialized Vascular Clinic

10. Blood Clot Retrieval Devices Market, by Application

  • 10.1. Deep Vein Thrombosis
    • 10.1.1. Distal Deep Vein Thrombosis
    • 10.1.2. Proximal Deep Vein Thrombosis
  • 10.2. Ischemic Stroke
    • 10.2.1. Acute Ischemic Stroke
    • 10.2.2. Subacute And Chronic Occlusion
  • 10.3. Pulmonary Embolism
    • 10.3.1. Massive Pulmonary Embolism
    • 10.3.2. Submassive Pulmonary Embolism

11. Blood Clot Retrieval Devices Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Blood Clot Retrieval Devices Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Blood Clot Retrieval Devices Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Analysis
    • 14.3.1. Medtronic plc
    • 14.3.2. Stryker Corporation
    • 14.3.3. Penumbra, Inc.
    • 14.3.4. Boston Scientific Corporation
    • 14.3.5. MicroPort Scientific Corporation
    • 14.3.6. Terumo Corporation
    • 14.3.7. Johnson & Johnson
    • 14.3.8. Integra LifeSciences Holdings Corporation
    • 14.3.9. Cardinal Health, Inc.
    • 14.3.10. AngioDynamics, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 9. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GCC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPEAN UNION BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. BRICS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. G7 BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. NATO BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BLOOD CLOT RETRIEVAL DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. BLOOD CLOT RETRIEVAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BLOOD CLOT RETRIEVAL DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ASPIRATION CATHETER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ASPIRATION CATHETER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ASPIRATION CATHETER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ASPIRATION CATHETER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ASPIRATION CATHETER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ASPIRATION CATHETER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SEQUENTIAL RETRIEVERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SEQUENTIAL RETRIEVERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SEQUENTIAL RETRIEVERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SEQUENTIAL RETRIEVERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SEQUENTIAL RETRIEVERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SEQUENTIAL RETRIEVERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SIMULTANEOUS RETRIEVERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SIMULTANEOUS RETRIEVERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SIMULTANEOUS RETRIEVERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SIMULTANEOUS RETRIEVERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SIMULTANEOUS RETRIEVERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SIMULTANEOUS RETRIEVERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY STENT RETRIEVER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY STENT RETRIEVER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY STENT RETRIEVER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY STENT RETRIEVER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY STENT RETRIEVER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY STENT RETRIEVER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY CARDIAC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY CARDIAC HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY CARDIAC HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY CARDIAC HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY CARDIAC HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY CARDIAC HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY NEUROVASCULAR CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY NEUROVASCULAR CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY NEUROVASCULAR CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY NEUROVASCULAR CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY NEUROVASCULAR CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY NEUROVASCULAR CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SPECIALIZED VASCULAR CLINIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SPECIALIZED VASCULAR CLINIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SPECIALIZED VASCULAR CLINIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SPECIALIZED VASCULAR CLINIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SPECIALIZED VASCULAR CLINIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SPECIALIZED VASCULAR CLINIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DISTAL DEEP VEIN THROMBOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DISTAL DEEP VEIN THROMBOSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DISTAL DEEP VEIN THROMBOSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DISTAL DEEP VEIN THROMBOSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DISTAL DEEP VEIN THROMBOSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DISTAL DEEP VEIN THROMBOSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PROXIMAL DEEP VEIN THROMBOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PROXIMAL DEEP VEIN THROMBOSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PROXIMAL DEEP VEIN THROMBOSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PROXIMAL DEEP VEIN THROMBOSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PROXIMAL DEEP VEIN THROMBOSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PROXIMAL DEEP VEIN THROMBOSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ACUTE ISCHEMIC STROKE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ACUTE ISCHEMIC STROKE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ACUTE ISCHEMIC STROKE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ACUTE ISCHEMIC STROKE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ACUTE ISCHEMIC STROKE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ACUTE ISCHEMIC STROKE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBACUTE AND CHRONIC OCCLUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBACUTE AND CHRONIC OCCLUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBACUTE AND CHRONIC OCCLUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBACUTE AND CHRONIC OCCLUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBACUTE AND CHRONIC OCCLUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBACUTE AND CHRONIC OCCLUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY MASSIVE PULMONARY EMBOLISM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY MASSIVE PULMONARY EMBOLISM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY MASSIVE PULMONARY EMBOLISM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY MASSIVE PULMONARY EMBOLISM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY MASSIVE PULMONARY EMBOLISM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY MASSIVE PULMONARY EMBOLISM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBMASSIVE PULMONARY EMBOLISM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBMASSIVE PULMONARY EMBOLISM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBMASSIVE PULMONARY EMBOLISM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBMASSIVE PULMONARY EMBOLISM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBMASSIVE PULMONARY EMBOLISM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBMASSIVE PULMONARY EMBOLISM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 141. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 145. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 147. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 160. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 162. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 164. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 166. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 168. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 170. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 178. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 182. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 184. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 186. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 188. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 190. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 232. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 234. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 236. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 244. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 245. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 250. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 251. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 252. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 253. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 254. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 255. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 256. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 259. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 260. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 261. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 262. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 283. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 288. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2025-2032 (USD MILLION)
  • TABLE 289. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 292. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 293. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 294. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 295. ASEAN BLOOD CLOT RETRIEVAL DEVIC